Interventional technology developer TriReme Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Chocolate percutaneous transluminal angioplasty balloon catheter.
Designed for the treatment of occluded peripheral arteries, Chocolate was developed in collaboration with TriReme's Quattro Vascular subsidiary in Singapore, according to TriReme. It incorporates a constraining structure over a semicompliant balloon to facilitate the formation of small modules, which can expand locally to facilitate plaque modification, TriReme said.
This design aims to lower the strain and trauma on the vessel wall, TriReme said.
